Arkolith/Insider Trading/NKGN/Form 4

Scott Kathleen D.

DirectorNKGen Biotech, Inc. (NKGN) · full profile →Form 4 · filed Dec 10, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 6, 2024Grant(A)300K—$0300K
Dec 6, 2024Grant(A)500K—$0500K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-107608) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML